MX2007016462A - Composiciones topicas para tratar la piel. - Google Patents

Composiciones topicas para tratar la piel.

Info

Publication number
MX2007016462A
MX2007016462A MX2007016462A MX2007016462A MX2007016462A MX 2007016462 A MX2007016462 A MX 2007016462A MX 2007016462 A MX2007016462 A MX 2007016462A MX 2007016462 A MX2007016462 A MX 2007016462A MX 2007016462 A MX2007016462 A MX 2007016462A
Authority
MX
Mexico
Prior art keywords
pharmaceutically acceptable
acceptable salt
compostions
topical skin
skin treating
Prior art date
Application number
MX2007016462A
Other languages
English (en)
Inventor
Kathleen L Clark
Jeffrey S Reynolds
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37596046&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007016462(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Publication of MX2007016462A publication Critical patent/MX2007016462A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fertilizers (AREA)

Abstract

Se describen composiciones y metodos topicos para usarse en la misma forma para tratar varias condiciones o desordenes de la piel. En un aspecto particular, estas composiciones comprenden una mezcla estable en almacenamiento de una composicion que contiene peroxido de benzoilo, un antibiotico o una sal o ester farmaceuticamente aceptable del mismo y un retinoide o una sal farmaceuticamente aceptable del mismo. En una modalidad alterna, estas composiciones comprenden una mezcla en almacenamiento estable de un retonoide o una sal farmaceuticamente aceptable del mismo y una composicion que contiene peroxido de benzoilo o una sal o ester farmaceuticamente aceptable del mismo.
MX2007016462A 2005-06-29 2006-06-29 Composiciones topicas para tratar la piel. MX2007016462A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69479905P 2005-06-29 2005-06-29
PCT/US2006/025376 WO2007002831A2 (en) 2005-06-29 2006-06-29 Topical skin treating compostions

Publications (1)

Publication Number Publication Date
MX2007016462A true MX2007016462A (es) 2008-04-22

Family

ID=37596046

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007016462A MX2007016462A (es) 2005-06-29 2006-06-29 Composiciones topicas para tratar la piel.

Country Status (14)

Country Link
US (1) US20070003585A1 (es)
EP (1) EP1898896A2 (es)
JP (1) JP2009500336A (es)
KR (1) KR20080059143A (es)
CN (1) CN101212959A (es)
AR (1) AR054805A1 (es)
AU (1) AU2006263646A1 (es)
BR (1) BRPI0611713A2 (es)
CA (1) CA2613221A1 (es)
IL (1) IL188487A0 (es)
MX (1) MX2007016462A (es)
RU (1) RU2008102510A (es)
TW (1) TW200800164A (es)
WO (1) WO2007002831A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US9868103B2 (en) * 2005-08-02 2018-01-16 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
MX2008012526A (es) 2006-03-31 2008-10-14 Stiefel Res Australia Pyt Ltd Gel espumoso en suspension.
US8080537B2 (en) 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
FR2903603B1 (fr) 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
SI2114392T1 (sl) * 2007-01-30 2016-01-29 Galderma Research & Development Uporaba adapalena in benzoil peroksida za dolgotrajno zdravljenje navadnih aken
US20100016443A1 (en) * 2007-02-01 2010-01-21 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
EP2109445B1 (en) 2007-02-01 2022-04-20 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
WO2009051839A1 (en) * 2007-10-18 2009-04-23 Medicis Pharmaceutical Corporation Aqueous retinoid and benzoyl peroxide gel
CN103142460B (zh) * 2007-11-30 2016-08-31 盖尔德马研究及发展公司 含有至少一种萘甲酸衍生物、过氧化苯甲酰和至少一种成膜剂的组合物、它们的制备方法及其用途
EP2282731A1 (en) * 2008-04-24 2011-02-16 Galderma Research & Development Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
US9132139B2 (en) * 2008-05-21 2015-09-15 Galderma Research & Development Maintenance therapy regime/regimen for the treatment of acne
MX2010013152A (es) 2008-06-05 2011-05-02 Dow Pharmaceutical Sciences Formulaciones farmaceuticas topicas que contienen una baja concentracion de peroxido de benzoilo en suspension en agua y un solvente organico miscibe en agua.
EP2453746A4 (en) * 2009-07-16 2013-04-24 Stiefel Laboratories TAZAROTENDERIVATE
WO2011101868A2 (en) * 2010-02-18 2011-08-25 Helios Pharmaceuticals Private Limited Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
AU2011231112B2 (en) * 2010-03-25 2013-11-07 Sol-Gel Technologies Ltd. Compositions for topical administration
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
AU2012245274B2 (en) * 2011-04-20 2016-09-22 Kao Usa, Inc. Self-tanning compositions having reduced Maillard reaction malodor
JP2014518265A (ja) 2011-06-30 2014-07-28 アラーガン インコーポレイテッド レチノイド局所用組成物および皮膚疾病を治療するための方法
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
RU2500395C1 (ru) * 2012-12-07 2013-12-10 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Мазевая композиция для местного применения с противоугревой фармакологической активностью
WO2016136925A1 (ja) * 2015-02-27 2016-09-01 マルホ株式会社 皮膚用組成物
CN107708665B (zh) 2015-03-23 2022-07-22 贝尔生物制药有限公司 用于皮肤病学用途的药用四环素组合物
WO2017188843A1 (ru) * 2016-04-29 2017-11-02 Елизавета Сергеевна ГРИШКОВА Лечебно-косметическое средство для профилактики и комплексного лечения дерматозов
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
GB2568758A (en) * 2017-11-28 2019-05-29 Chitty Nicholas Sun protection and acne treatment and prevention composition
WO2019164984A1 (en) * 2018-02-20 2019-08-29 BioPharmX, Inc. Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics
CA3102288A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
AU2020322173A1 (en) 2019-08-01 2022-02-17 Bausch Health Ireland Limited Topical compositions
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609674A (en) * 1984-06-11 1986-09-02 Richardson-Vicks Inc. Stabilized clear benzoyl peroxide compositions
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US5089509A (en) * 1988-09-15 1992-02-18 Allergan, Inc. Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US5721275A (en) * 1989-06-07 1998-02-24 Bazzano; Gail S. Slow release vehicles for minimizing skin irritancy of topical compositions
SK43994A3 (en) * 1991-10-16 1995-01-12 Richardson Vicks Inc Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
US5254109A (en) * 1992-12-07 1993-10-19 Creative Products Resource Associates, Ltd. Separately packaged applicator pads for topical delivery of incompatable drugs
DK0706370T4 (da) * 1993-07-01 2005-04-18 Yamanouchi Europ Bv Anvendelse af nonioniske overfladeaktive stoffer i stabile topiske retinoidsammensætninger
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US6001380A (en) * 1994-04-12 1999-12-14 Creative Products Resource, Inc. Medicated applicator sheet for topical drug delivery
US5470884A (en) * 1994-05-19 1995-11-28 Procter & Gamble Anti-acne compositions
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
US5449519C1 (en) * 1994-08-09 2001-05-01 Revlon Consumer Prod Corp Cosmetic compositions having keratolytic and anti-acne activity
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5948416A (en) * 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
AR006049A1 (es) * 1996-03-01 1999-07-21 Johnson & Johnson Consumer Una emulsion de aceite en agua
GR1002807B (el) * 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5753757A (en) * 1996-11-13 1998-05-19 Xerox Corporation Electroluminescent polymer compositions and processes thereof
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
BR9810985A (pt) * 1997-07-08 2000-08-15 Dsm Nv Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
US6017549A (en) * 1997-09-30 2000-01-25 E-L Management Corp. Non-irritating cosmetic and pharmaceutical compositions
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
EP1100490B1 (en) * 1998-07-28 2006-12-13 Susan Bershad Short contact treatment of acne and photoaging with topical retinoids
US6017938A (en) * 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6730308B1 (en) * 1999-03-08 2004-05-04 Allergan, Inc. Tazarotene and alpha hydroxy acid treatment for psoriasis and/or photodamage
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20030044432A1 (en) * 2000-09-29 2003-03-06 Manetta Vincent E. Acne treating composition
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20020193321A1 (en) * 2000-12-12 2002-12-19 Mohan Vishnupad Dual dispenser for aesthitically acceptable delivery of anhydrous skin treatment compositions
US6495158B1 (en) * 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems

Also Published As

Publication number Publication date
AU2006263646A1 (en) 2007-01-04
WO2007002831A3 (en) 2007-06-21
JP2009500336A (ja) 2009-01-08
IL188487A0 (en) 2008-08-07
US20070003585A1 (en) 2007-01-04
WO2007002831A2 (en) 2007-01-04
AR054805A1 (es) 2007-07-18
CA2613221A1 (en) 2007-01-04
EP1898896A2 (en) 2008-03-19
CN101212959A (zh) 2008-07-02
BRPI0611713A2 (pt) 2011-12-20
RU2008102510A (ru) 2009-08-10
TW200800164A (en) 2008-01-01
KR20080059143A (ko) 2008-06-26

Similar Documents

Publication Publication Date Title
MX2007016462A (es) Composiciones topicas para tratar la piel.
WO2007092312A3 (en) Topical skin treating compositions
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
MY143795A (en) Tetrahydropyridoindole derivatives
HK1156515A1 (en) Pharmaceutical compositions and methods for accelerating wound healing
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MY151457A (en) Topical formulation and uses thereof
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
NO20080141L (no) Indanderivater som modulatorer av ionekanaler
TW200507830A (en) Bronchodilating β -agonist compositions and methods
NO20071742L (no) Kinazoliner som er nyttige som modulatorer av ionekanaler
WO2005116086A3 (en) Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
WO2006113498A3 (en) 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases
EP2513343A4 (en) METHODS AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION
ZA200710332B (en) Bicyclic derivatives as modulators of ion channels
WO2006120681A3 (en) Compositions and methods for skin care
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
MX2010001125A (es) Composiciones incluyendo receptor androgeno de degradacion (ard) ponteciadores y metodos de tratamiento profilactico o terapeutico de trastornos de la piel y la caida de cabello.
EP2425874A3 (en) Use of a vitamin D compound and an additional therapeutic agent for the treatment of cancer
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
WO2007058989A3 (en) Quinazolines useful as modulators of voltage gated ion channels
AU2008321142A8 (en) Heterocyclic derivatives as modulators of ion channels

Legal Events

Date Code Title Description
FA Abandonment or withdrawal